✦ LIBER ✦

An open trial of pargyline in the treatment of attention deficit disorder, residual type

✍ Scribed by Paul H. Wender; David R. Wood; Fred W. Reimherr; Mark Ward

Book ID: 119094343
Publisher: Elsevier Science
Year: 1983
Tongue: English
Weight: 660 KB
Volume: 9
Category: Article
ISSN: 0165-1781
DOI: 10.1016/0165-1781(83)90006-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open trial of buspirone in the treatm

An open trial of buspirone in the treatment of attention-deficit disorder

✍ Helmut Niederhofer 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB 👁 1 views

## Abstract ## Objective Medications such as clonidine have been shown to facilitate calming, to enhance frustration tolerance, and to reduce aggression in attention deficit disorder (ADD) patients. The use of buspirone was studied as an alternative because of its longer excretion half‐life, decre

Treatment of the attention deficit disor

Treatment of the attention deficit disorder (residual type) with moclobemide

✍ L Chamorro; I Lopez 📂 Article 📅 1995 🏛 Elsevier Science 🌐 French ⚖ 108 KB

An open trial of bupropion for the treat

An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder

✍ Timothy E Wilens; Jefferson B Prince; Thomas Spencer; Stephanie L Van Patten; Ro 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 124 KB

421. - An open label trial of venlafaxin

421. - An open label trial of venlafaxine in adults with attention deficit disorder

✍ L.A. Adler; S. Resnick; M. Kunz; O. Devinsky 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Treatment of chronic cocaine abuse and a

Treatment of chronic cocaine abuse and attention deficit disorder, residual type, with magnesium pemoline

✍ Weiss, Roger D.; Pope, Harrison G.; Mirin, Steven M. 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 289 KB

Duloxetine in the treatment of adolescen

Duloxetine in the treatment of adolescents with attention deficit/hyperactivity disorder: an open-label study

✍ Javad Mahmoudi-Gharaei; Nasrin Dodangi; Mehdi Tehrani-Doost; Toktam Faghihi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

Objective The main aim of this study was to explore the efficacy and safety of duloxetine, a serotonin and norepinephrine reuptake inhibitor, in the treatment of adolescents with attention deficit/hyperactivity disorder (ADHD). Methods Seventeen adolescents aged 11-18 years, diagnosed with ADHD, par